New York, NY, March 11, 2021 – The Rohatyn Group (“TRG”), a global, US-based asset management firm, today announced that it has completed an investment in the specialized pet accessories company MyFamily Srl (“MyFamily” or the “Company”), establishing a partnership with the Company’s founder, Alessandro…

New York, NY, May 12, 2020 – The Rohatyn Group (“TRG”), an emerging markets focused asset management firm, today announced that it has completed an investment in Optimapharm d.d.  (“Optimapharm” or the “Company”), to establish a partnership with the company’s founders Gordana Gregurić Čičak and…

New York, NY, November 5, 2019 –  The Rohatyn Group (“TRG”), an emerging markets focused asset management firm, today announced an investment in Amethyst Radiotherapy (“Amethyst” or the “Company”), obtaining co-control of the Company alongside the two co-founders. Amethyst is one of the largest operators of…

New York, NY, October 9, 2018 – The Rohatyn Group (“TRG”), an emerging markets asset management firm, today announced the successful completion of its acquisitions of Pet Product SRL (“Pet Product” or “Animax”), one of the leading pet supplies companies in Romania, and MIMAJA d.o.o….

Transaction completes landmark exit from two leading Turkish retail companies BusinessWire 22 June 2015 The Rohatyn Group (“TRG”), a leading emerging markets asset management firm, today announced that Fennella Sarl, controlled by TRG Growth Fund II, has completed its final exit from Beymen Mağazacılık A.Ş….

Advance Properties OOD total shareholding in Bulgarian pharmaceuticals company Huvepharma AD is now 100% New York – November 20, 2014 – The Rohatyn Group (“TRG”), an independent investment firm focused on emerging markets, today announced that TRG Growth Fund II has finalised the sale of…